172 related articles for article (PubMed ID: 23693117)
21. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
Araghi M; Arnold M; Rutherford MJ; Guren MG; Cabasag CJ; Bardot A; Ferlay J; Tervonen H; Shack L; Woods RR; Saint-Jacques N; De P; McClure C; Engholm G; Gavin AT; Morgan E; Walsh PM; Jackson C; Porter G; Møller B; Bucher O; Eden M; O'Connell DL; Bray F; Soerjomataram I
Gut; 2021 Jan; 70(1):114-126. PubMed ID: 32482683
[TBL] [Abstract][Full Text] [Related]
22. "There's Not Enough Bodies to Do the Demand": An Exploration of Key Stakeholder Views on the Role of Health Service Capacity in Shaping Cancer Outcomes in 7 International Cancer Benchmarking Partnership Countries.
Seguin M; Morris M; McKee M; Nolte E
Int J Health Policy Manag; 2022 Jul; 11(7):1024-1034. PubMed ID: 33589567
[TBL] [Abstract][Full Text] [Related]
23. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK.
Pritchard C; Hickish T
Lancet; 2011 Apr; 377(9772):1149; author reply 1149-50. PubMed ID: 21459201
[No Abstract] [Full Text] [Related]
24. A comparative analysis: international variation in PET-CT service provision in oncology-an International Cancer Benchmarking Partnership study.
Lynch C; Reguilon I; Langer DL; Lane D; De P; Wong WL; Mckiddie F; Ross A; Shack L; Win T; Marshall C; Revheim ME; Danckert B; Butler J; Dizdarevic S; Louzado C; Mcgivern C; Hazlett A; Chew C; O'connell M; Harrison S
Int J Qual Health Care; 2021 Feb; 33(1):. PubMed ID: 33306102
[TBL] [Abstract][Full Text] [Related]
25. Promoting equitable global health research: a policy analysis of the Canadian funding landscape.
Plamondon K; Walters D; Campbell S; Hatfield J
Health Res Policy Syst; 2017 Aug; 15(1):72. PubMed ID: 28851388
[TBL] [Abstract][Full Text] [Related]
26. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study.
Benitez Majano S; Di Girolamo C; Rachet B; Maringe C; Guren MG; Glimelius B; Iversen LH; Schnell EA; Lundqvist K; Christensen J; Morris M; Coleman MP; Walters S
Lancet Oncol; 2019 Jan; 20(1):74-87. PubMed ID: 30545752
[TBL] [Abstract][Full Text] [Related]
27. Do perceived barriers to clinical presentation affect anticipated time to presenting with cancer symptoms: an ICBP study.
Donnelly C; Quaife S; Forbes L; Boylan J; Tishelman C; Gavin A
Eur J Public Health; 2017 Oct; 27(5):808-813. PubMed ID: 28957476
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer.
Lüchtenborg M; Morris EJA; Tataru D; Coupland VH; Smith A; Milne RL; Te Marvelde L; Baker D; Young J; Turner D; Nishri D; Earle C; Shack L; Gavin A; Fitzpatrick D; Donnelly C; Lin Y; Møller B; Brewster DH; Deas A; Huws DW; White C; Warlow J; Rashbass J; Peake MD
Thorax; 2018 Apr; 73(4):339-349. PubMed ID: 29079609
[TBL] [Abstract][Full Text] [Related]
29. Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study.
Cabasag CJ; Butler J; Arnold M; Rutherford M; Bardot A; Ferlay J; Morgan E; Møller B; Gavin A; Norell CH; Harrison S; Saint-Jacques N; Eden M; Rous B; Nordin A; Hanna L; Kwon J; Cohen PA; Altman AD; Shack L; Kozie S; Engholm G; De P; Sykes P; Porter G; Ferguson S; Walsh P; Trevithick R; Tervonen H; O'Connell D; Bray F; Soerjomataram I
Gynecol Oncol; 2020 Apr; 157(1):234-244. PubMed ID: 32005583
[TBL] [Abstract][Full Text] [Related]
30. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007.
Maringe C; Walters S; Rachet B; Butler J; Fields T; Finan P; Maxwell R; Nedrebø B; Påhlman L; Sjövall A; Spigelman A; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Morris E; McGahan CE; Tracey E; Turner D; Richards MA; Coleman MP;
Acta Oncol; 2013 Jun; 52(5):919-32. PubMed ID: 23581611
[TBL] [Abstract][Full Text] [Related]
31. Negative cancer beliefs, recognition of cancer symptoms and anticipated time to help-seeking: an international cancer benchmarking partnership (ICBP) study.
Pedersen AF; Forbes L; Brain K; Hvidberg L; Wulff CN; Lagerlund M; Hajdarevic S; Quaife SL; Vedsted P
BMC Cancer; 2018 Apr; 18(1):363. PubMed ID: 29609534
[TBL] [Abstract][Full Text] [Related]
32. Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership.
Maringe C; Walters S; Butler J; Coleman MP; Hacker N; Hanna L; Mosgaard BJ; Nordin A; Rosen B; Engholm G; Gjerstorff ML; Hatcher J; Johannesen TB; McGahan CE; Meechan D; Middleton R; Tracey E; Turner D; Richards MA; Rachet B;
Gynecol Oncol; 2012 Oct; 127(1):75-82. PubMed ID: 22750127
[TBL] [Abstract][Full Text] [Related]
33. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK.
Lachmann P
Lancet; 2011 Apr; 377(9772):1149; author reply 1149-50. PubMed ID: 21459202
[No Abstract] [Full Text] [Related]
34. Evidence-based benchmarks for use of cancer surgery in high-income countries: a population-based analysis.
Perera SK; Jacob S; Sullivan R; Barton M
Lancet Oncol; 2021 Feb; 22(2):173-181. PubMed ID: 33485459
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.
Walters S; Maringe C; Butler J; Rachet B; Barrett-Lee P; Bergh J; Boyages J; Christiansen P; Lee M; Wärnberg F; Allemani C; Engholm G; Fornander T; Gjerstorff ML; Johannesen TB; Lawrence G; McGahan CE; Middleton R; Steward J; Tracey E; Turner D; Richards MA; Coleman MP;
Br J Cancer; 2013 Mar; 108(5):1195-208. PubMed ID: 23449362
[TBL] [Abstract][Full Text] [Related]
36. Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
Cabasag CJ; Arnold M; Piñeros M; Morgan E; Brierley J; Hofferkamp J; Kehoe S; Butler J; Bucher O; Bray F; Soerjomataram I; Parkin DM
Int J Cancer; 2021 Sep; 149(6):1239-1246. PubMed ID: 33990959
[TBL] [Abstract][Full Text] [Related]
37. National benchmarking between the Nordic countries on the quality of care.
Mainz J; Hjulsager M; Og MT; Burgaard J
J Surg Oncol; 2009 Jun; 99(8):505-7. PubMed ID: 19072992
[TBL] [Abstract][Full Text] [Related]
38. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007.
Walters S; Maringe C; Coleman MP; Peake MD; Butler J; Young N; Bergström S; Hanna L; Jakobsen E; Kölbeck K; Sundstrøm S; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Linklater KM; McGahan CE; Steward J; Tracey E; Turner D; Richards MA; Rachet B;
Thorax; 2013 Jun; 68(6):551-64. PubMed ID: 23399908
[TBL] [Abstract][Full Text] [Related]
40. Cancer-related costs should be allocated in a comparable way-benchmarking costs of cancer in Nordic countries 2012-2017.
Torkki P; Leskelä RL; Bugge C; Torfadottir JE; Karjalainen S
Acta Oncol; 2022 Oct; 61(10):1216-1222. PubMed ID: 36151990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
